Impacts of rapid mass vaccination against SARS-CoV2 in an early variant of concern hotspot

Jörg Paetzold; Janine Kimpel; Katie Bates; Michael Hummer; Florian Krammer; Dorothee von Laer; Hannes Winner

doi:10.1038/s41467-022-28233-8

Nature Communications (Feb 2022)

Impacts of rapid mass vaccination against SARS-CoV2 in an early variant of concern hotspot

Jörg Paetzold,
Janine Kimpel,
Katie Bates,
Michael Hummer,
Florian Krammer,
Dorothee von Laer,
Hannes Winner

Affiliations

Jörg Paetzold: University of Salzburg, Department of Economics
Janine Kimpel: Institute of Virology, Department of Hygiene, Microbiology and Public Health, Medical University of Innsbruck
Katie Bates: Department of Medical Statistics, Informatics and Health Economics, Medical University of Innsbruck
Michael Hummer: The Austrian National Public Health Institute (Gesundheit Österreich GmbH, GÖG)
Florian Krammer: Department of Microbiology, Icahn School of Medicine at Mount Sinai
Dorothee von Laer: Institute of Virology, Department of Hygiene, Microbiology and Public Health, Medical University of Innsbruck
Hannes Winner: University of Salzburg, Department of Economics

DOI: https://doi.org/10.1038/s41467-022-28233-8
Journal volume & issue: Vol. 13, no. 1
pp. 1 – 7

Abstract

Read online

Schwaz, Austria, experienced SARS-CoV-2 outbreaks caused by variants of concern in early 2021 and conducted a mass vaccination campaign in response, with 70% of the adult population vaccinated after 5 days. Here, the authors show that this campaign resulted in reduced infections and hospitalisations.

Published in Nature Communications

ISSN: 2041-1723 (Online)
Publisher: Nature Portfolio
Country of publisher: United Kingdom
LCC subjects: Science
Website: https://www.nature.com/ncomms/

About the journal